SiMoA
The company reported a 4 percent decline in Q3 revenues and a 30 percent drop in consumables revenue while addressing issues with assay quality control.
Quanterix, WuXi AppTec to Open Joint Lab in Shanghai
The lab will provide researchers in the Asia-Pacific region with access to Quanterix's Simoa technology and biomarker testing, development, and validation services.
In a study published this week, researchers presented a Simoa-based assay for tuberculosis that could ultimately be packaged as a point-of-care test.
Quanterix Raises $49.7 in Stock Offering
The company sold 2.2 million shares at an average price of $22.73 per share under a $50 million at-the-market equity facility it filed in March 2019.
Quanterix Q1 Revenues Up 64 Percent
The company posted Q1 revenues of $12.3 million, up from $7.5 million in Q1 2018 and above the consensus Wall Street estimate of $10.2 million.